These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8858111

  • 21. Effect of changes in the CD44 gene on tumour cell invasion in gliomas.
    Bouterfa H, Janka M, Meese E, Kerkau S, Roosen K, Tonn JC.
    Neuropathol Appl Neurobiol; 1997 Oct; 23(5):373-9. PubMed ID: 9364462
    [Abstract] [Full Text] [Related]

  • 22. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
    Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB, Bullard KM.
    Cancer Res; 2004 Jul 01; 64(13):4569-76. PubMed ID: 15231668
    [Abstract] [Full Text] [Related]

  • 23. CD44: structure, function, and association with the malignant process.
    Naor D, Sionov RV, Ish-Shalom D.
    Adv Cancer Res; 1997 Jul 01; 71():241-319. PubMed ID: 9111868
    [Abstract] [Full Text] [Related]

  • 24. Stage-specific alternative cplicing of CD44 and alpha 6 beta 1 integrin in colorectal tumorigenesis.
    Wittig BM, Goebel R, Weg-Remers S, Pistorius G, Feifel G, Zeitz M, Stallmach A.
    Exp Mol Pathol; 2001 Apr 01; 70(2):96-102. PubMed ID: 11263953
    [Abstract] [Full Text] [Related]

  • 25. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 26. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
    Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS.
    J Neurosurg; 1995 May 15; 82(5):858-63. PubMed ID: 7536236
    [Abstract] [Full Text] [Related]

  • 27. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
    Zhu D, Bourguignon LY.
    Cell Motil Cytoskeleton; 1998 May 15; 39(3):209-22. PubMed ID: 9519902
    [Abstract] [Full Text] [Related]

  • 28. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY.
    Cancer Res; 2007 Mar 01; 67(5):2089-97. PubMed ID: 17332338
    [Abstract] [Full Text] [Related]

  • 29. Alternative mRNA splicing in colon cancer causes loss of expression of neural cell adhesion molecule.
    Huerta S, Srivatsan ES, Venkatesan N, Peters J, Moatamed F, Renner S, Livingston EH.
    Surgery; 2001 Nov 01; 130(5):834-43. PubMed ID: 11685193
    [Abstract] [Full Text] [Related]

  • 30. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM, Givehchian M, Dürst M, Schneider A, Costa S, Melsheimer P, Lacroix J, Zöller M, Doeberitz MK.
    Clin Cancer Res; 1995 Oct 01; 1(10):1125-32. PubMed ID: 9815903
    [Abstract] [Full Text] [Related]

  • 31. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
    Levesque MC, Haynes BF.
    Cell Immunol; 1999 May 01; 193(2):209-18. PubMed ID: 10222064
    [Abstract] [Full Text] [Related]

  • 32. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
    Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD.
    Stem Cells; 2006 Apr 01; 24(4):928-35. PubMed ID: 16306150
    [Abstract] [Full Text] [Related]

  • 33. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A, Del Prete F, Girnita L, Martegani MP, Natali PG, Bartolazzi A.
    Melanoma Res; 2003 Aug 01; 13(4):325-37. PubMed ID: 12883358
    [Abstract] [Full Text] [Related]

  • 34. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
    Subramaniam V, Gardner H, Jothy S.
    Exp Mol Pathol; 2007 Dec 01; 83(3):341-6. PubMed ID: 17945213
    [Abstract] [Full Text] [Related]

  • 35. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells.
    Nakano T, Matsui T, Ota T.
    Anticancer Res; 1996 Dec 01; 16(6B):3577-84. PubMed ID: 9042224
    [Abstract] [Full Text] [Related]

  • 36. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
    Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R.
    Cancer Res; 2005 Jul 01; 65(13):5812-7. PubMed ID: 15994957
    [Abstract] [Full Text] [Related]

  • 37. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
    Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DG, Spring F, Aruffo A.
    J Cell Biol; 1995 Dec 01; 131(6 Pt 1):1623-33. PubMed ID: 8522617
    [Abstract] [Full Text] [Related]

  • 38. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I, Dehmel A, Naundorf H, Finke LH.
    Anticancer Res; 1997 Dec 01; 17(5A):3633-45. PubMed ID: 9413216
    [Abstract] [Full Text] [Related]

  • 39. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
    Zhu D, Bourguignon LY.
    J Cell Physiol; 2000 May 01; 183(2):182-95. PubMed ID: 10737894
    [Abstract] [Full Text] [Related]

  • 40. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
    Wallach SB, Friedmann A, Naor D.
    Cancer Detect Prev; 2000 May 01; 24(1):33-45. PubMed ID: 10757121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.